Research

Biogen Advances Spinal Muscular Atrophy (SMA) Clinical Research with New Study, DEVOTE, Evaluating a Higher Dose of SPINRAZA and Additional Data in a Broad Range of Patients

September 18, 2019
Posted in ,

Biogen today announced updates to the SPINRAZA (nusinersen) clinical development program including the initiation of a new global clinical trial, DEVOTE. The DEVOTE study will […]

Read More ›

Zolgensma Update and Approval Webinars Now Available Online

September 6, 2019
Posted in , ,

A recording of last week’s webinar on Zolgensma updates is now available on Cure SMA’s YouTube channel. A presentation of the webinar can be found […]

Read More ›

2019 Researcher Meeting Summary: Clinical Research Studies for SMA

September 6, 2019
Posted in ,

The annual SMA Researcher Meeting is the largest research meeting in the world specifically focused on SMA. This year, we had a record setting 735 […]

Read More ›

2019 SMA Researcher Meeting Summary: Basic Research Podium Presentations

August 26, 2019
Posted in , ,

The annual SMA Researcher Meeting is the largest research meeting in the world specifically focused on SMA. This year, we had a record setting 735 […]

Read More ›

2019 SMA Researcher Meeting Summary: Special Session on Spinal and Neuromuscular Circuitry: Exploring Defects in SMA and Potential Therapeutic Targets

August 12, 2019
Posted in , ,

The annual SMA Researcher Meeting is the largest research meeting in the world specifically focused on SMA. This year, we had a record setting 735 […]

Read More ›

Biogen Announces New NURTURE Data at the 2019 Annual SMA Conference

July 1, 2019
Posted in , ,

Biogen today announced new results from the NURTURE study, adding data to the longest study of spinal muscular atrophy (SMA) in pre-symptomatic infants (n=25). These […]

Read More ›

Updated SMA Drug Pipeline Now Available

June 28, 2019
Posted in , ,

We’ve recently released an update to the SMA drug pipeline. This latest version includes: 23 active programs, including two approved therapies. 15 pharmaceutical partners. 6 […]

Read More ›

Cytokinetics Releases New Data from Reldesemtiv Clinical Study at the 2019 Annual SMA Conference

June 28, 2019
Posted in , ,

Cytokinetics, Incorporated, today announced that data from two preclinical studies of reldesemtiv were presented at the 2019 Annual Cure SMA Conference in Anaheim, CA, showing […]

Read More ›

Family Friendly Research Poster Session Presenters Announced

June 11, 2019
Posted in , ,

The Family Friendly Research Poster Session will be held on Saturday, June 29th from 6:30pm to 8:00pm at the 2019 Annual SMA Conference.  The Family […]

Read More ›

Biogen Issues Q2 Community Statement on Spinraza

June 6, 2019
Posted in , ,

Dear members of the SMA community, We are grateful for the opportunity to continue to help support individuals with spinal muscular atrophy (SMA), their caregivers […]

Read More ›
Scroll to Top